P38/SAPK2 INHIBITOR (SB202190) 1MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

The p38/SAPK2 Inhibitor (SB 202190) controls the biological activity of p38/SAPK2. This small molecule/inhibitor is primarily used for Biochemicals applications.

Potent inhibitor of p38 alpha/SAPK2a and p38 beta/SAPK2b kinases.

Biochem/physiol Actions

Protein Target: p38/SAPK2

Target Sub-Family: CMGC

Inhibitor Type: Kinase

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Physical form

C₂0H₁₄FN₃O

Quality

Routinely evaluated in a kinase assay as an inhibitor.

Storage and Stability

3 years at -20°C